GSK , Brentford , UK.
Valesta c/o GSK , Mechelen , Belgium.
Hum Vaccin Immunother. 2019;15(10):2475-2481. doi: 10.1080/21645515.2019.1589288. Epub 2019 Apr 4.
We evaluated the applicability of a infection (CDI) risk index developed for patients at hospital discharge to identify persons at high-risk of CDI in a primary care population. This retrospective observational study used data from the UK Clinical Practice Research Datalink, linked with Hospital Episodes Statistics. The risk index was based on the following patient characteristics: age, previous hospitalizations, days in hospital, and prior antibiotics use. Individual risk scores were calculated by summing points assigned to pre-defined categories for each characteristic. We assessed the association of risk factors with CDI by multivariate logistic regression. The estimated CDI incidence rate was 4/10,000 and 2/10,000 person-years in 2008 and 2012, respectively. On an index with a maximal risk of 19, a cut-off for high risk of ≥7 had sensitivity, specificity and positive predictive values of 80%, 87% and 12%, respectively. A high-risk person had a ~ 35% higher risk of CDI than a low-risk person. Multivariate risk factor analysis indicated a need to reconsider the relative risk scores. The CDI risk index can be applied to the UK primary care population and help identify study populations for vaccine development studies. Reassessing the relative weights assigned to risk factors could improve the index performance in this setting.
我们评估了一种针对出院患者的感染(CDI)风险指数在识别初级保健人群中 CDI 高危患者方面的适用性。这项回顾性观察性研究使用了来自英国临床实践研究数据链接和医院发病统计数据。该风险指数基于以下患者特征:年龄、先前住院、住院天数和先前使用抗生素。通过对每个特征的预定义类别进行评分相加,计算出个体风险评分。我们通过多变量逻辑回归评估了风险因素与 CDI 的关联。2008 年和 2012 年 CDI 的估计发病率分别为 4/10000 和 2/10000 人年。在最高风险为 19 的指数中,≥7 的高风险截断值的敏感性、特异性和阳性预测值分别为 80%、87%和 12%。高风险患者的 CDI 风险比低风险患者高约 35%。多变量风险因素分析表明需要重新考虑相对风险评分。CDI 风险指数可应用于英国初级保健人群,并有助于确定疫苗开发研究的研究人群。重新评估风险因素的相对权重可以提高该指数在这种情况下的性能。